智通财经APP讯，鹰瞳科技-B(02251)公布，2025年12月16日耗资约2.61万港元回购2300股股份。 ...

鹰瞳科技-B(02251)公布，2025年12月16日耗资约2.61万港元回购2300股股份。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 北京鷹瞳科技發展股份有限公司(「本公司」) (於中華人民共和國註冊成立的股份有限责任公司) 呈交日期： 2025年12月16日 確認 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02251 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 ...

Core Insights - Huawei has officially launched the AI Data Platform for the healthcare sector, aimed at addressing the cost, quality, and accessibility challenges in the medical field through advanced technologies [1][4] - The AI Data Platform supports the "Rui Bin 2" medical intelligence system, developed in collaboration with West China Hospital, providing comprehensive diagnostic services for patients and research support for doctors [4] - The Chinese government is actively promoting the digital transformation of healthcare, with policies aimed at integrating AI into various medical applications, projecting significant growth in the AI healthcare market [5] Industry Developments - The AI healthcare market in China is expected to reach 115.7 billion yuan by 2025, with a compound annual growth rate (CAGR) of 10.5% from 2022 to 2028, potentially growing to 159.8 billion yuan by 2028 [5] - Several listed companies are forming AI healthcare industry clusters, integrating AI technologies into various medical applications, such as blood purification and imaging diagnostics [6] - The application of AI in healthcare is seen as a key turning point, driven by technological advancements and policy support, creating a new theme for industry innovation [7] Company Highlights - Eagle Eye Technology (02251) is recognized for its AI retinal imaging diagnostic solutions, which can automatically capture and analyze retinal images, identifying various diseases [8] - Yidu Tech (02158) has made significant progress in AI healthcare innovation, establishing a closed-loop system of data, algorithms, and scenarios to accelerate business deployment [8] - Ping An Good Doctor (01833) reported a 19.5% year-on-year revenue increase, attributed to advancements in AI healthcare, prompting analysts to raise its target price [9] - iFlytek Medical Technology (02506) leads in the medical AI field with its comprehensive medical model, showcasing strong performance in various core capabilities [9]

Core Viewpoint - Eagle Vision Technology-B (02251) announced a share buyback on December 3, 2025, spending HKD 232,000 to repurchase 20,000 shares at a price range of HKD 11.59 to HKD 11.60 per share [1] Summary by Category - **Company Actions** - The company executed a share buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback was HKD 232,000, which reflects the company's financial strategy [1] - **Share Price Details** - The repurchase price per share was set between HKD 11.59 and HKD 11.60, suggesting a targeted approach to managing share value [1]

Group 1 - The company, Eagle Vision Technology-B (02251), announced a share buyback on December 3, 2025, spending HKD 232,000 to repurchase 20,000 shares [1] - The buyback price per share ranged from HKD 11.59 to HKD 11.60 [1]

Core Viewpoint - Eagle Vision Technology-B (02251) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Categories Company Actions - The company plans to repurchase 20,000 shares at a total cost of HKD 232,000 [1] - The buyback price per share ranges from HKD 11.59 to HKD 11.60 [1] Financial Implications - The total expenditure for the buyback represents a strategic investment in the company's own equity, potentially enhancing shareholder value [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 北京鷹瞳科技發展股份有限公司(「本公司」) (於中華人民共和國註冊成立的股份有限责任公司) 呈交日期： 2025年12月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02251 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | ...

Core Viewpoint - Multiple companies conducted share buybacks on December 2, 2025, with Tencent Holdings leading in both volume and monetary value [1] Group 1: Buyback Details - Tencent Holdings (00700) repurchased 1.028 million shares for a total of 636 million [2] - Xiaomi Group-W (01810) repurchased 2.5 million shares for a total of 102 million [2] - COSCO Shipping Holdings (01919) repurchased 3 million shares for a total of 41.053 million [2] - China Feihe (06186) repurchased 4 million shares for a total of 16.74 million [2] - Gushengtang (02273) repurchased 378,400 shares for a total of 10.9452 million [2] Group 2: Cumulative Buyback Data - Tencent Holdings has a cumulative buyback of 82.018 million shares, representing 0.893% of its total share capital [2] - Xiaomi Group-W has a cumulative buyback of 78.2954 million shares, representing 0.300% of its total share capital [2] - COSCO Shipping Holdings has a cumulative buyback of 60.543 million shares, representing 2.102% of its total share capital [2] - China Feihe has a cumulative buyback of 195 million shares, representing 2.149% of its total share capital [2] - Gushengtang has a cumulative buyback of 10.4139 million shares, representing 4.395% of its total share capital [2] Group 3: Other Notable Buybacks - Other companies such as Kingsoft (03888), Fuhua Group (02038), and Weigao Group (01066) also participated in the buyback activities, with varying amounts and percentages of total shares repurchased [2][3] - The buyback activities reflect a trend among companies to return capital to shareholders amid market conditions [1]

Core Viewpoint - Eagle Vision Technology-B (02251) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will spend HKD 472,400 to repurchase 40,600 shares [1]